You have changed your country from  to  . Please be aware that this will change the currency in the purchasing process.

Reassurance, Refunds & Replacements

If your product does not perform as described on this datasheet, we will refund or replace your product...

Read our guarantee »
 

ILP2 peptide (2/13) (ab9665)

CodeSizePriceAbpointsAvailability
    
 
  • -
  •   
  •   
  •   
  •  
  •   
  •   
Updating...

Overview

Product name

ILP2 peptide (2/13)

Protein description

Synthetic peptide: TGYEARLITFGT, corresponding to amino acids 2/13 of Human ILP2 This peptide was used as an immunogen for ab9664 - ILP2 antibody.

Properties

Form

Liquid

Storage instructions

Shipped at 4°C. Upon delivery aliquot and store at -20°C or -80°C. Avoid repeated freeze / thaw cycles.

Storage buffer

PBS with 0.1% BSA 0.02% sodium azide pH7.2

Concentration

Concentration information loading...

Sequence notes

TGYEARLITF GT amino acids 2 to 13 of human ILP-2 (1).

Sequence

TGYEARLITF GT

Applications

Show applications key

Our Abpromise guarantee covers the use of ab9665 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

  • Blocking

     

Application notes

The peptide is used for blocking the activity of anit-ILP-2 antibody (ab9664) - Incubate the peptide with equal volume of antibody for 30 min at 37°C.

Protein info

Function

Protects against apoptosis mediated by BAX.

Tissue specificity

Testis specific in normal tissues.

Sequence similarities

Belongs to the IAP family.
Contains 1 BIR repeat.
Contains 1 RING-type zinc finger.

Cellular localization

Cytoplasm.

Target information above from: UniProt accessionQ96P09 The UniProt Consortium
The Universal Protein Resource (UniProt) in 2010
Nucleic Acids Res. 38:D142-D148 (2010).

Information by UniProt

References for ILP2 peptide (2/13) (ab9665)

This product has been referenced in:

  • Sáinz Net al. Leptin administration favors muscle mass accretion by decreasing FoxO3a and increasing PGC-1alpha in ob/ob mice. PLoS One 4:e6808 (2009). WB; Mouse.Read more (PubMed: 19730740) »

See 1 publication for this product

Publishing research using ab9665? Please let us know so that we can cite the reference in this datasheet

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"